View up-to-date information on Samsung Biologics Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
04 Jun 2022 | Novartis Enters Manufacturing Agreement with Samsung Biologics for its products | Contract Service Agreement |
Novartis AG
|
Samsung Biologics Co Ltd |
12 Apr 2022 | Samsung Biologics to Raise USD2.6 Billion in Rights Offering of Shares | Equity Offering | - |
Samsung Biologics Co Ltd |
27 Jan 2022 | Samsung Biologics Acquires Remaining Stake in Samsung Bioepis from Biogen | Acquisition |
Samsung Biologics Co Ltd
|
Samsung Bioepis Co Ltd
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer